<DOC>
	<DOCNO>NCT02906644</DOCNO>
	<brief_summary>This study plan compare efficacy nicotine patch / lorcaserin combination treatment vs. nicotine patch alone term lead reduction smoke behavior withdrawal symptom .</brief_summary>
	<brief_title>Combination Nicotine Patch / Lorcaserin Smoking Cessation</brief_title>
	<detailed_description>This study propose investigate potential efficacy combination two FDA-approved agent , nicotine patch lorcaserin , smoke cessation treatment . The nicotine patch provide sustain low dose nicotine nicotine receptor agonist . Lorcaserin , serotonin 5-hydroxytryptamine receptor 2C ( 5-HT2C ) agonist , drug FDA-approved weight loss , also recently show efficacious smoke cessation . Given drug act distinct mechanism hop combination prove efficacious either drug alone . It also hypothesize combination reduce weight gain commonly see smoke cessation .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>1865 year old ; Smoke average least 10 cigarette per day ; Have smoke least one cumulative year ; Have expire air CO reading least 10ppm ; Body weight &gt; 50 kg ( 110 lb . ) Able read understand English ; Express desire quit smoke next thirty day . Hypertension ( systolic &gt; 140 mm Hg , diastolic &gt; 100 mm Hg , couple history hypertension ) ; subject previous diagnosis hypertension may screen blood pressure 160/100 . Hypotension symptom ( systolic &lt; 90 mm Hg , diastolic &lt; 60 mm Hg ) . Participants history hypertension may , however , allow participate study study physician physician assistant determine condition stable , controlled medication , way jeopardize individual 's safety . Coronary heart disease , diagnose coronary angiogram ; Lifetime history heart attack ; Cardiac rhythm disorder ( irregular heart rhythm ) ; Chest pain last month ( unless history , exam , ECG clearly indicate noncardiac source ) ; Symptomatic cardiac ( heart ) disorder ( include limit valvular heart disease , heart murmur , heart failure ) ; Diagnosis liver disease kidney disorder ( except kidney stone , gallstone ) ; Gastrointestinal problem ( e.g . Celiac disease , Crohn 's dx Ulcerative Colitis ) disease gastroesophageal reflux heartburn ; Active ulcer past 30 day ; Currently symptomatic lung disorder/disease ( include limit chronic obstructive pulmonary disease ( COPD ) , emphysema , asthma ) ; Brain abnormality ( include limit stroke , brain tumor , seizure disorder ) ; Migraine headaches occur frequently per week ; Recent , unexplained fainting spell ; Problems give blood sample ; Diabetes ( unless control diet exercise alone screen glucose less 180mg/dcl HbA1c less 7 % ) ; Current cancer treatment cancer past six month ( except basal squamous cell skin cancer ) ; HIV , Hepatitis B , Hepatitis C History tuberculosis recent positive purify protein derivative ( PPD ) test Other major medical condition ; Current psychiatric disease ( exception anxiety disorder , obsessive compulsive disorder ( OCD ) ADHD ) ; Suicidal ideating ( think way commit suicide ) ( within past 10 year ) lifetime occurrence attempt suicide ; Current depression The Patient Health Questionnaire ( PHQ9 ) Depression use screen current ( within 2 week ) depression . Potential subject score &gt; 9 ( score &gt; 0 item # 9 ( `` Thoughts would well dead , hurt way '' ) exclude study participation , , discretion study physician , refer appropriate psychiatric treatment ; Bulimia anorexia ; BMI &lt; 18.5 kg/m2 ; Prior use fenfluramine dexfenfluramine Use ( within past 30 day ) : Illegal drug ( urine drug screen positive tetrahydrocannabinol ( THC ) , Cocaine , Amphetamine , Opiates , Methamphetamines , phencyclidine ( PCP ) , Benzodiazepines , Barbiturates ) , Unless recent use prescription Opiates , Benzodiazepines management acute symptom . Experimental ( investigational ) drug ; Psychiatric medication include antidepressant ( selective serotonin reuptake inhibitor ( SSRIs ) , serotonin norepinephrine reuptake inhibitor ( SNRIs ) , tricyclic antidepressant ( TCAs ) , monoamine oxidase inhibitor ( MAOIs ) , St. John 's Wort ) , lithium , antipsychotic medication know affect smoking cessation ( e.g . clonidine ) ; Phentermine , triptans , tryptophan , linezolid , dextromethorphan , opiates , tramadol , dopamine agonist ; Any agent documented correlation increase incidence valvulopathy and/or pulmonary hypertension ( e.g. , cyproheptadine , trazodone , nefazodone , amoxapine , tricyclic antidepressant , mirtazapine , pergolide , ergotamine , methysergide ) ( anticipate use study ) ; Smokeless tobacco ( chew tobacco , snuff ) , pip ecigarettes ; Wellbutrin , bupropion , Zyban , Chantix , varenicline , nicotine patch , nicotine replacement therapy smoke cessation aid . Concurrent use serotonergic agent/combination associate severe serotonin syndrome ( within past 30 day ) ; Use cigar , cigarillo , pipe , Hookah , dissolvable nicotine , snuff , chew tobacco per month . Use ecigarettes per month . Selfreport consume 4 alcoholic drink 1 day per week ; Significant adverse reaction lorcaserin nicotine patch past . Current participation recent participation ( past 30 day ) another smoking study investigator Center another research facility . Current participation another research study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Nicotine addiction</keyword>
	<keyword>Cigarette smoking</keyword>
	<keyword>Smoking cessation</keyword>
	<keyword>lorcaserin</keyword>
	<keyword>Belviq</keyword>
	<keyword>Nicotine patch</keyword>
</DOC>